MHA Insider Trading Activity and SEC Form 4 Filings
MHA insider trading summary
No open-market insider purchases or sales of Manhattan Pharmaceuticals Inc (MHA) have been reported on SEC Form 4 in the past 12 months.
Latest MHA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 30, 2007 | Neil Herskowitz | Director | Buy | $50K (55,555 @ $0.90) |
| Jul 18, 2006 | Neil Herskowitz | Director | Buy | $2K (2,500 @ $0.61) |
| Jul 13, 2006 | Neil Herskowitz | Director | Buy | $2K (2,500 @ $0.68) |
| Jul 12, 2006 | Michael Weiser | Director | Buy | $2K (3,200 @ $0.75) |
| Jul 12, 2006 | Michael Weiser | Director | Buy | $1K (1,800 @ $0.72) |
| Jul 11, 2006 | Neil Herskowitz | Director | Buy | $3K (4,500 @ $0.71) |
| Jul 10, 2006 | Neil Herskowitz | Director | Buy | $365 (500 @ $0.73) |
| Jul 10, 2006 | Douglas Abel | President and CEO | Buy | $4K (5,000 @ $0.75) |
| Jan 10, 2006 | Neil Herskowitz | Director | Buy | $18K (14,200 @ $1.30) |
| Nov 18, 2005 | Douglas Abel | President and CEO | Buy | $6K (5,000 @ $1.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.